SCHEMBL5561195

SCHEMBL5561195

COS(=O)(=O)[O-].Cc1ccc(Nc2ccc[n+](C)c2)cc1O

nearest known ligand 0.38

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B2 P37059 2/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ KDR P35968 4/20 0.37
▸ RET P07949 1/20 0.37
▸ KIF5B P33176 1/20 0.37
▸ APOBEC3A P31941 2/20 0.36
▸ APOBEC3G Q9HC16 2/20 0.36
▸ PABPC1 P11940 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.34
▸ BCHE P06276 1/20 0.34
▸ CYP1A2 P05177 2/20 0.33
▸ CYP2D6 P10635 2/20 0.33
▸ CYP2C9 P11712 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ EGFR P00533 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ NSD2 O96028 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5564793 0.88 KDR (0.40) HSD17B2L3MBTL1KDRRETKIF5B
Iodide SCHEMBL5565778 0.87 KDR (0.41) HSD17B2L3MBTL1KDRRETKIF5B
Hydrochloric Acid SCHEMBL5565999 0.87 KDR (0.41) HSD17B2L3MBTL1KDRRETKIF5B
SCHEMBL6130234 0.82 TUBB4A (0.48) HSD17B2L3MBTL1ALDH1A1CYP1A2CYP2D6
SCHEMBL5560529 0.73 PIK3CG (0.31) L3MBTL1KDR
Hydrochloric Acid SCHEMBL5565982 0.70 ALDH1A1 (0.40) HSD17B2L3MBTL1KDRRETKIF5B
SCHEMBL20544415 0.70 BCHE (0.37) L3MBTL1APOBEC3AAPOBEC3GPABPC1ALDH1A1
SCHEMBL11689059 0.69 USP2 (0.42) ALDH1A1BCHEUSP2
SCHEMBL7555415 0.69 HPGD (0.54) L3MBTL1KDRALDH1A1EGFRMEN1
Fluoride Ion SCHEMBL18740626 0.68 HDAC8 (0.48) L3MBTL1APOBEC3AAPOBEC3GPABPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7229479-B2 Method of coloring porous material CIBA SPECIALTY CHEMICALS CORPORATION (US) 2007-06-12 — — US disclosed
US-20060162095-A1 Method of colouring porous material CIBA SPECIALTY CHEMICALS CORP. 2006-07-27 — — US disclosed
EP-1534226-A1 METHOD OF COLOURING POROUS MATERIAL Ciba SC Holding AG (CH) 2005-06-01 — — EP disclosed
WO-2004019897-A1 METHOD OF COLOURING POROUS MATERIAL CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2004-03-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060162095-A1 Method of colouring porous material ACR, HLA-C, TYR HSD17B2 1251/4885L3MBTL1 4611/4885KDR 4077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback